0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Alcohol Use and Mortality from Coronary Heart Disease: The Role of High-Density Lipoprotein Cholesterol

Il Suh, MD, PhD; B. Jessica Shaten, MS; Jeffrey A. Cutler, MD; and Lewis H. Kuller, MD, DPH
[+] Article and Author Information

Grant Support: By National Institutes of Health/National Heart, Lung and Blood Institute Contract HC22971.

Requests for Reprints: B. Jessica Shaten, MS, Research Fellow, Coordinating Centers for Biometric Research, Division of Biostatistics, School of Public Health, University of Minnesota, 2221 University Avenue Southeast, Suite 200, Minneapolis MN 55414-3080.

Current Author Addresses: Dr. Suh: Department of Preventive Medicine and Public Health, Yonsei University College of Medicine, 134 Shinchon-Dong Seodaeman-Gu, Seoul, Korea.

Ms. Shaten: Coordinating Centers for Biometric Research, Division of Biostatistics, School of Public Health, University of Minnesota, 2221 University Avenue SE, Suite 200, Minneapolis, MN 55414-3080.

Dr. Cutler: Division of Epidemiology and Clinical Applications, National Heart, Lung and Blood Institute, Federal Building, Room 604, Bethesda, MD 20814.

Dr. Kuller: Graduate School of Public Health, University of Pittsburgh, A527 Crabtree Hall, 130 DeSoto Street, Pittsburgh, PA 15261.


for the Multiple Risk Factor Intervention Trial Research Group


Ann Intern Med. 1992;116(11):881-887. doi:10.7326/0003-4819-116-11-881
Text Size: A A A

Objective: To study the association between alcohol consumption and death from coronary heart disease and to determine the extent to which the association can be explained by the high-density lipoprotein (HDL) cholesterol level.

Design: A cohort study involving men enrolled in the Multiple Risk Factor Intervention Trial (MRFIT).

Setting: Community-based study.

Participants: Men (n = 11 688) at high risk for developing coronary heart disease but without clinical evidence of it. More than 90% of the men were white, and the average age was 46 years. Five percent of the men abstained from alcohol during the trial, 81% consumed fewer than 21 alcoholic drinks per week, and 14% consumed more than 21 alcoholic drinks per week.

Measurements: Average alcohol intake over 7 years was calculated for MRFIT participants who were alive at the end of the trial and who had at least three follow-up records of alcohol consumption. Post-trial mortality during a 3.8-year period was assessed.

Results: The adjusted relative risk for death from coronary heart disease for each increase of 7 drinks per week was 0.89 (95% Cl, 0.80 to 1.00), with an apparent dose-response relationship. The average HDL level was associated with the average alcohol intake in a least-squares regression model (β = -0.0074; P < 0.01). When the average HDL level was included in the proportional hazards model for mortality from coronary heart disease, the absolute value of the coefficient for average drinks per week declined 45%, yielding an adjusted relative risk for each additional 7 drinks per week of 0.94 (Cl, 0.84 to 1.05).

Conclusion: In middle-aged men who are light to moderate drinkers, the inverse association between alcohol consumption and death from coronary heart disease can be explained, in large part, by the HDL cholesterol level, which increases with alcohol consumption. However, alcohol consumption cannot be recommended because of the known adverse effects of excess alcohol use.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)